2-202376511-AGGCGGCGGC-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_001204.7(BMPR2):​c.-936_-928delGGCGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.0083 ( 11 hom., cov: 16)

Consequence

BMPR2
NM_001204.7 5_prime_UTR

Scores

Not classified

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 3.43

Publications

3 publications found
Variant links:
Genes affected
BMPR2 (HGNC:1078): (bone morphogenetic protein receptor type 2) This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, May 2020]
BMPR2 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pulmonary hypertension, primary, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 2-202376511-AGGCGGCGGC-A is Benign according to our data. Variant chr2-202376511-AGGCGGCGGC-A is described in ClinVar as [Benign]. Clinvar id is 3041823.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00834 (1049/125852) while in subpopulation AFR AF = 0.0148 (503/34012). AF 95% confidence interval is 0.0137. There are 11 homozygotes in GnomAd4. There are 514 alleles in the male GnomAd4 subpopulation. Median coverage is 16. This position passed quality control check.
BS2
High AC in GnomAd4 at 1049 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BMPR2NM_001204.7 linkc.-936_-928delGGCGGCGGC 5_prime_UTR_variant Exon 1 of 13 ENST00000374580.10 NP_001195.2 Q13873-1
BMPR2XM_011511687.2 linkc.-936_-928delGGCGGCGGC 5_prime_UTR_variant Exon 1 of 13 XP_011509989.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BMPR2ENST00000374580.10 linkc.-936_-928delGGCGGCGGC 5_prime_UTR_variant Exon 1 of 13 1 NM_001204.7 ENSP00000363708.4 Q13873-1
ENSG00000273456ENST00000724884.1 linkn.154+271_154+279delGCCGCCGCC intron_variant Intron 1 of 1
ENSG00000273456ENST00000724885.1 linkn.106+113_106+121delGCCGCCGCC intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00834
AC:
1049
AN:
125748
Hom.:
11
Cov.:
16
show subpopulations
Gnomad AFR
AF:
0.0148
Gnomad AMI
AF:
0.00138
Gnomad AMR
AF:
0.00932
Gnomad ASJ
AF:
0.00659
Gnomad EAS
AF:
0.00334
Gnomad SAS
AF:
0.00407
Gnomad FIN
AF:
0.0112
Gnomad MID
AF:
0.00735
Gnomad NFE
AF:
0.00482
Gnomad OTH
AF:
0.00643
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00834
AC:
1049
AN:
125852
Hom.:
11
Cov.:
16
AF XY:
0.00853
AC XY:
514
AN XY:
60230
show subpopulations
African (AFR)
AF:
0.0148
AC:
503
AN:
34012
American (AMR)
AF:
0.00922
AC:
109
AN:
11820
Ashkenazi Jewish (ASJ)
AF:
0.00659
AC:
21
AN:
3186
East Asian (EAS)
AF:
0.00335
AC:
14
AN:
4174
South Asian (SAS)
AF:
0.00408
AC:
12
AN:
2942
European-Finnish (FIN)
AF:
0.0112
AC:
92
AN:
8244
Middle Eastern (MID)
AF:
0.00769
AC:
2
AN:
260
European-Non Finnish (NFE)
AF:
0.00482
AC:
284
AN:
58914
Other (OTH)
AF:
0.00699
AC:
11
AN:
1574
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00175
Hom.:
30

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

BMPR2-related disorder Benign:1
Feb 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375624016; hg19: chr2-203241234; API